Febuxostat is available as 40- and 80-mg tablets. The recommended starting dosage is 40 mg orally once daily. If serum uric acid concentrations are not less than 6 mg/dL after two weeks ...

Mean serum urate levels were 6.0 mg/dL among men and 4.8 mg/dL among ... An alternative XOI, Febuxostat, was launched in the US in 2009 with the hope of treating individuals with gout, however ...

Current first-line therapies like allopurinol and febuxostat can be very effective ... hit a target uric acid levels in the blood of 1.5 mg/dL or lower for at least 80% of the sixth months ...

Febuxostat does not appear to increase the risk for major adverse cardiovascular events when compared with no urate-lowering ...

The U.S. Food and Drug Administration this week granted permission for the use of a new cancer drug from China despite ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...

Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.

An alternative XOI, Febuxostat, was launched in the US in 2009 ... for each potential application (e.g., investigational new drug application (IND), NDA, biologics license application (BLA ...